These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22983586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia.
    Machaczka M, Gossart M.
    Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191
    [No Abstract] [Full Text] [Related]

  • 3. Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.
    Mariani S, Giona F, Basciani S, Brama M, Gnessi L.
    Lancet; 2008 Jul 12; 372(9633):111-112. PubMed ID: 18620939
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia.
    Eskazan AE, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.
    Leuk Lymphoma; 2014 Dec 12; 55(12):2935-7. PubMed ID: 24650055
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT.
    Khoo TL, Catalano A, Supple S, Chong L, Yeoh SC, Yeung S, Iland H.
    Leuk Lymphoma; 2013 Jan 12; 54(1):186-8. PubMed ID: 22712835
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
    Ostro D, Lipton J.
    Leuk Lymphoma; 2007 Jan 12; 48(1):195-6. PubMed ID: 17325868
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 Jan 12; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 18. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
    Rousselot P, Larghero J, Raffoux E, Calvo F, Tulliez M, Giraudier S, Rybojad M.
    Br J Haematol; 2003 Mar 12; 120(6):1091-2. PubMed ID: 12648085
    [No Abstract] [Full Text] [Related]

  • 19. Imatinib mesylate induced immune thrombocytopenia.
    Rajappa S, Varadpande L, Paul TR, Digumarti R.
    Leuk Lymphoma; 2007 Nov 12; 48(11):2261-3. PubMed ID: 17926182
    [No Abstract] [Full Text] [Related]

  • 20. Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
    Mabed M, Elhefni AM, Damnhouri G.
    Leuk Lymphoma; 2012 Nov 12; 53(11):2310-1. PubMed ID: 22462614
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.